Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Social Media Discussions Provide new Insight About Perceptions of Hydroxyurea in the Sickle Cell Community
source: American Journal of Hematology
year: 2019
authors: Walker AL, Gaydos LM, Farzan R, De Castro L, Jonassaint C
summary/abstract:Hydroxyurea (HU) has proven efficacious for treating sickle cell disease (SCD) and is recommended for most patients. However, HU is underutilized and reasons for lack of uptake are unclear. Past qualitative studies to identify barriers have been small and limited to clinical settings. Thus, to better understand barriers to HU there is a need to explore perceptions of patients and families from the broader community. We conducted a qualitative study of Facebook messages posted in an online sickle cell support group to identify barriers and facilitators to hydroxyurea use.
We collected a total of 22 223 user‐generated original messages and comments posted in the SCD Unite group between January 2014 and November 2015. From these messages, we identified those containing any of the following terms: “Hydrea,” “Droxia,” “Hydroxycarbamide,” “Hydroxurea,” “Hydroxy,” “HU,” “Urea,” and “hydro*,” along with the comments associated with these posts. All nontext based posts (ie, pictures, videos, and links) were excluded.
The resultant data set included 145 total original messages and 2618 associated comments. We performed content coding and analysis on all 145 original message posts followed by thematic analysis of a select subset of discussion threads, which were defined as a single original message plus their associated comments.
organization: University of Pittsburgh, USA; Emory University, USADOI: 10.1002/ajh.25430
read more full text
+myBinderRelated Content
-
HydroxyureaHydroxyurea (Hydrea) is used alone or wi...
-
Shared Decision Making for Hydroxyurea Treatment Initiation in Children With Sickle Cell AnemiaClinical trials have demonstrated hydrox...
-
Current Advocacy Work in Sickle Cell Disease: The Global PerspectiveJoin the Global Alliance of Sickle Cell ...
-
Effort set to help sickle cell patients manage medsVanderbilt University Medical Center is ...
-
SCDF: BabySteps Parent Education MeetingBabySteps is a FREE monthly program for ...
-
FDA Approves Hydroxyurea Tablets for Pediatric Patients With Sickle Cell AnemiaThe US Food and Drug Administration (FDA...
-
Aisha Walker, PhDDr. Walker is a Research Assistant Profe...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.